KK and KKA y Mice: Models of type 2 diabetes with obesity

Animal Models of Diabetes, Second Edition: Frontiers in Research

Volumn , Issue , 2007, Pages 335-347

  Taketomi, Shigehisa ^a  

^a Technology Department / Yonezawa Hamari Chemicals Ltd 2 4300 18   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056983540     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (70)

1. Adachi Y, Yoshikawa Y, Yoshida J, et al. (2006) Improvement in diabetes, obesity and hypertension in type 2 diabetic KKA(y) mice by bis(allixunato)oxovanadium(IV) complex. Biochem Biophys Res Commun (published in PubMed ahead of print).
2. Aizawa-Abe M, Ogawa Y, Masuzaki H, et al. (2000) Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 105:1243-1252.
3. Albert P, Engblom L, Edling N, et al. (2002) Selective inhibition of 11ß-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycemic mice. Diabetologia 45:1528-1532.
4. Albert P, Nilsson C, Selen G, et al. (2003) Selective inhibition of 11ß-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144:4755-4762.
5. Berger J, Bailey P, Biswas C, et al. (1966) Thiazolidinediones produce a conformational change in peroxisomal proliferation-activated receptor-γ: Binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137:4189-4195.
6. Bray GA, York DA. (1979) Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 59:719-809.
7. Bultman S, Michaud EJ, Woychik RP. (1992) Molecular characterization of the mouse agouti locus. Cell 71:1195-1204.
8. Camerini-Davalos RA, Oppermann W, Mittl R, et al. (1970) Studies of vascular and other lesions in KK mice. Diabetologia 6:324-329.
9. Chen HO, Charlat LA, Tartaglia EA, et al. (1966) Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-495.
10. Danforth CH. (1927) Hereditary adiposity in mice. J Heredity 18:153-162.
11. DeFronzo RA. (1997) Pathogenesis of type II diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5:177-269.
12. Diani AR, Sawada GA, Zhang NY, et al. (1987) The KKAy mouse: A model for the rapid development of glomerular capillary basement membrane thickening. Blood Vessels 24:297-303.
13. Dulin WE, Gerritsen GC, Chang AY. (1983) Experimental and spontaneous diabetes in animals. In Diabetes Mellitus: Theory and Practice, ed. M. Ellenberg, H. Rifkin. Medical Examination Publishing Co., New York, 361-408.
14. Emoto M, Matsutani H, Kimura S, et al. (1982) Nephropathy in KK mice treated with a limited diet. J Jpn Diabetes Soc 25:1211-1219.
15. Frederich R, Hamann A, Anderson S, et al. (1995) Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311-1314.
16. Fujita T, Sugiyama Y, Taketomi S, et al. (1983) Reduction of insulin resistance in obese and/or diabetic animals by 5-(4-(1-methylcyclohexylmethoxy)benzyl)-thiazolidine-2,4- dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent. Diabetes 32:804-810.
17. Hayase M, Ogawa Y, Katsuura, G, et al. (1996) Regulation of obese gene expression in KK mice and congenic lethal yellow obese KKAy mice. Am J Physiol 271:E333-E339.
18. Herberg L, Gries FA, Hesse-Wortmann C. (1970) Effect of weight and cell size on hormoneinduced lipolysis in New Zealand obese mice and American obese hyperglycemic mice. Diabetologia 6:300-305.
19. Hofmann C, Lorenz K, Braithwaite SS, et al. (1994) Altered gene expression for tumor necrosis factor-a and its receptors during drug and dietary modulation of insulin resistance. Endocrinlogy 134:264-270.
20. Hofmann C, Lorenz K, Colca JR. (1991) Glucose transport deficiency in diabetic animals is corrected by treatment with oral antihyperglycemic agent pioglitazone. Endocrinology 129:1915-1925.
21. Hotamisligil GS, Budavari A, Murray D, et al. (1994) Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-a. J Clin Invest 94:1543-1549.
22. Hotamisligil GS, Spiegelman BM. (1994) Tumor necrosis factor: A key component of the obesity-diabetes link. Diabetes 43:1271-1278.
23. Iida M, Murakami T, Ishida K, et al. (1996) Substitution at codon 269 (glutamine→proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat. Biochem Biophys Res Commun 224:597-604.
24. Ikeda H, Taketomi S, Sugiyama Y, et al. (1990) Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneim Forsch/Drug Res 40:156-162.
25. Iwatsuka H, Ishikawa E, Shimakawa K, et al. (1974) The role of genetic background of KK strain in pathogenesis of diabetes: Polygenic inheritance of a sensitivity to a diabetogenic action of obesity. J Takeda Res Lab 33:248-251.
26. Iwatsuka H, Ishikawa E, Shino A. (1974) Remission of diabetic syndromes in advanced age of genetically obese and diabetic mice, yellow KK. J Takeda Res Lab 33:203-212.
27. Iwatsuka H, Matsuo T, Shino A, et al. (1970) Metabolic disturbance of KK mice in chemical diabetes. J Takeda Res Lab 29:685-692.
28. Iwatsuka H, Shino A. (1970) Studies on diabetogenic action of obesity in mice: Congenital insulin resistance of KK mice. Endocr Jpn 17:535-540.
29. Iwatsuka H, Shino A, Suzuoki Z. (1970) General survey of diabetic features of yellow KK mice. Endocr Jpn 17:23-35.
30. Iwatsuka H, Taketomi S, Matsuo T, et al. (1974) Congenitally impaired hormone sensitivity of the adipose tissue of spontaneously diabetic mice, KK. Validity of thrifty genotype in KK mice. Diabetologia 10:611-616.
31. Kondo K, Nozawa K, Tomita T, et al. (1957) Inbred strains resulting from Japanese mice. Bull Exp Animals 6:107-112.
32. Lee GH, Proenca R, Montez JM, et al. (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635.
33. Masuzaki H, Ogawa Y, Aizawa-Abe M, et al. (1999) Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation. Usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes 48:1615-1622.
34. Matsuo T, Furuno K, Shimakawa K. (1971) Factors affecting development of hyperglycemia in KK mice. J Takeda Res Lab 30:307-313.
35. Matsuo T, Iwatsuka H, Suzuoki Z. (1971) Metabolic disturbance of KK mice in overt diabetes. Endocr J 18:501-506.
36. Matsuo T, Shino A. (1972) Induction of diabetic alterations by goldthioglucose obesity in KK, ICR and C57BL mice. Diabetologia 8:391-397.
37. Matsuo T, Shino A, Iwatsuka H, et al. (1970) Induction of overt diabetes in KK mice by dietary means. Endocr J 17:477-488.
38. Michaud EJ, Bultman SJ, Klebig ML, et al. (1994) A molecular mode for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation. Proc Natl Acad Sci USA 91:2562-2566.
39. Nakamura M. (1962) A diabetic strain of the mouse. Proc Jpn Acad 38:348-352.
40. Nakamura M, Yamada K. (1963) A further study of the diabetic (KK) strain of the mouse: F1 and F2 offspring of the cross between KK and C57BL/6J mice. Proc Jpn Acad 38:489-493.
41. Nakamura M, Yamada K. (1967) Studies on diabetic (KK) strain of the mouse. Diabetologia 3:212-221.
42. Neel JV. (1962) Diabetes mellitus: A “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet 14:353-362.
43. Nishimura M. (1969) Breeding of mice strains for diabetes mellitus. Exp Anim (Tokyo) 18:147-157.
44. Ogawa Y, Masuzaki H, Hosoda K, et al. (1999) Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes 48:1822-1829.
45. Olefsky JM. (1977) Mechanism of decreased insulin responsiveness of large adipocytes. Endocrinology 100:1169-1177.
46. Phillips MS, Liu Q, Hammond HA, et al. (1996) Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 13:18-19.
47. Rask E, Olsson T, Soderberg S, et al. (2001) Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86:1418-1421.
48. Reddi AS, Oppermann W, Patel DG, et al. (1978) Diabetic microangiopathy in KK mice. III. Effect of prolonged glyburide treatment on glomerulosclerosis. Exp Mol Pathol 29:92-101.
49. Richardson DK, Czech MP. (1978) Primary role of decreased fatty acid synthesis in insulin resistance of large rat adipocytes. Am J Physiol 234:E182-E189.
50. Sasaki M, Uehara S, Ohta H, et al. (2004) Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice. Life Sci 75:869-880.
51. Seckl JR, Chapman KE. (1997) The 11ß-hydroxysteroid dehydrogenase system, a determinant of glucocorticoid and mineralocorticoid action. Medical and physiological aspects of the 11ß-hydroxysteroid dehydrogenase system. Eur J Biochem 249:361-364.
52. Shike T, Gohda T, Tanimoto M, et al. (2005) Chromosomal mapping of a quantitative trait locus for the development of albuminuria in diabetic KK/Ta mice. Nephrol Dial Transplant 20:879-885.
53. Shike T, Hirose S, Kobayashi M, et al. (2001) Susceptibility and negative epistatic loci contributing to type 2 diabetes and related phenotypes in a KK/Ta mouse model. Diabetes 50:1943-1948.
54. Shino A, Iwatsuka H. (1970) Morphological observations on pancreatic islets of spontaneous diabetic mice, yellow KK. Endocr Jpn 17:459-476.
55. Soret MG, Peterson T, Wyse BM, et al. (1977) Renal amyloidosis in KK mice that may be misinterpreted as diabetic glomerulosclerosis. Arch Pathol Lab Med 101:464-468.
56. Stewart PM, Krozowski ZS. (1999) 11ß-Hydroxysteroid dehydrogenase. Vitam Horm 57:249-324.
57. Suto J, Matsuura S, Imamura K, et al. (1998a) Genetic analysis of non-insulin-dependent diabetes mellitus in KK and KK-Ay mice. J Eur Endocr 139:654-661.
58. Suto J, Matsuura S, Imamura K, et al. (1998b) Genetics of obesity in KK mouse and effects of Ay allele on quantitative regulation. Mammalian Genome 9:506-510.
59. Suto J, Sekikawa K. (2002) A quantitative trait locus that accounts for glucose intolerance maps to chromosome 8 in hereditary obese KK-Ay mice. Int J Obesity 26:1517-1519.
60. Taketomi S, Fujita T, Yokono K. (1988) Insulin receptor and postbinding defects in KK mouse adipocytes and improvement by ciglitazone. Diabetes Res Clin Pract 5:125-134.
61. Taketomi S, Ikeda H, Ishikawa E, et al. (1982) Determination of overall insulin sensitivity in diabetic mice, KK. Horm Metab Res 14:14-18.
62. Taketomi S, Tsuda M, Matsuo T, et al. (1973) Alterations of hepatic enzyme activities in KK and yellow KK mice with various diabetic states. Horm Metab Res 5:333-339.
63. Taylor BA, Tarantino LM, Phillips SJ. (1999) Gender-influenced obesity QTLs identified in a cross involving the KK type II diabetes-prone mouse strain. Mammalian Genome 10:963-968.
64. Tontonoz P, Hu E, Spiegelman BM. (1994) Stimulation of adipogenesis in fibroblasts by PPAR2, a lipid activated transcription factor. Cell 79:1147-1156.
65. Treser G, Oppermann W, Ehrenreich T, et al. (1968) Glomerular lesions in a strain of genetically diabetic mice. Proc Soc Exp Biol Med 129:820-823.
66. Wehner H, Hohn O, Faix-Shade U, et al. (1972) Glomerular changes in mice with spontaneous hereditary diabetes. Lab Invest 27:331-340.
67. Wilson TM, Cobb JE, Cowan DJ, et al. (1966) The structure-activity relationship between peroxisome proliferation-activated receptor γ agonism and antihyperglycemic activity of thiazolidinediones. J Med Chem 39:665-668.
68. Wyse BM, Dulin WE. (1974) Further characterization of diabetes-like abnormalities in the T-KK mouse. Diabetologia 10:617-623.
69. Yamauchi T, Kamon J, Waki H, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946.
70. Zhang YR, Proenca R, Maffei M, et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432.